Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer's disease: The paving dawn for future therapy. - Al-Kuraishy HM; Fahad EH; Jabir MS; Rafeeq MF; Sulaiman GM; Amara IB; Albuhadily AK; Al-Gareeb AI (Neuroscience, 2026)